Anteris Technologies Global Corp.
Company Profile
Business description
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
Contact
9 Sherwood Road
Toowong Tower, Level 3, Suite 302
Toowong,QLD4066
AUST: +61 731523200
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,766.00 | 75.10 | 0.86% |
CAC 40 | 7,763.84 | 26.64 | 0.34% |
DAX 40 | 24,091.62 | 160.95 | 0.67% |
Dow JONES (US) | 42,519.64 | 214.16 | 0.51% |
FTSE 100 | 8,787.02 | 12.76 | 0.15% |
HKSE | 23,680.73 | 168.24 | 0.72% |
NASDAQ | 19,398.96 | 156.34 | 0.81% |
Nikkei 225 | 37,775.04 | 328.23 | 0.88% |
NZX 50 Index | 12,479.28 | 152.05 | 1.23% |
S&P 500 | 5,970.37 | 34.43 | 0.58% |
S&P/ASX 200 | 8,539.30 | 72.60 | 0.86% |
SSE Composite Index | 3,376.58 | 14.61 | 0.43% |